tiprankstipranks
Advertisement
Advertisement

DE:9IB Stock Latest News

Infant Bacterial Therapeutics Issues Corrected Notice for 2026 AGM in Stockholm
Company AnnouncementsInfant Bacterial Therapeutics Issues Corrected Notice for 2026 AGM in Stockholm
8d ago
Infant Bacterial Therapeutics Calls 2026 AGM With Focus on Governance, Capital and Incentives
PremiumCompany Announcements
Infant Bacterial Therapeutics Calls 2026 AGM With Focus on Governance, Capital and Incentives
11d ago
Infant Bacterial Therapeutics Advances IBP-9414 Toward Accelerated Approval
PremiumCompany Announcements
Infant Bacterial Therapeutics Advances IBP-9414 Toward Accelerated Approval
14d ago
IBT’s IBP-9414 Neonatal Trial Results Published in Leading Pediatric Journal
PremiumCompany Announcements
IBT’s IBP-9414 Neonatal Trial Results Published in Leading Pediatric Journal
1M ago
Infant Bacterial Therapeutics Narrows Loss as FDA Backs Accelerated Path for IBP-9414
PremiumCompany Announcements
Infant Bacterial Therapeutics Narrows Loss as FDA Backs Accelerated Path for IBP-9414
2M ago
Infant Bacterial Therapeutics Partners with BioConnection for Drug Production
PremiumCompany AnnouncementsInfant Bacterial Therapeutics Partners with BioConnection for Drug Production
4M ago
IBT Pursues Accelerated Approval for IBP-9414 After FDA Discussions
Premium
Company Announcements
IBT Pursues Accelerated Approval for IBP-9414 After FDA Discussions
5M ago
Infant Bacterial Therapeutics Partners with Recipharm for IBP-9414 Production
Premium
Company Announcements
Infant Bacterial Therapeutics Partners with Recipharm for IBP-9414 Production
5M ago
Infant Bacterial Therapeutics Advances IBP-9414 Amid Financial Challenges
PremiumCompany Announcements
Infant Bacterial Therapeutics Advances IBP-9414 Amid Financial Challenges
5M ago
Infant Bacterial Therapeutics AB Forms Nomination Committee for 2026 AGM
PremiumCompany Announcements
Infant Bacterial Therapeutics AB Forms Nomination Committee for 2026 AGM
6M ago
Infant Bacterial Therapeutics Advances Drug Registration for IBP-9414
PremiumCompany Announcements
Infant Bacterial Therapeutics Advances Drug Registration for IBP-9414
6M ago
IBT’s IBP-9414 Shows Promise in Reducing NEC Consequences
PremiumCompany Announcements
IBT’s IBP-9414 Shows Promise in Reducing NEC Consequences
7M ago
Infant Bacterial Therapeutics Advances Toward Launch of Breakthrough Infant Drug
PremiumCompany AnnouncementsInfant Bacterial Therapeutics Advances Toward Launch of Breakthrough Infant Drug
8M ago
IBT to Present Phase III Trial Results at ESPGHAN 2025
Premium
Company Announcements
IBT to Present Phase III Trial Results at ESPGHAN 2025
11M ago
Infant Bacterial Therapeutics AGM Highlights Strategic Resolutions
Premium
Company Announcements
Infant Bacterial Therapeutics AGM Highlights Strategic Resolutions
11M ago
IBT Advances FDA Submission for Key Drug Candidate
PremiumCompany Announcements
IBT Advances FDA Submission for Key Drug Candidate
11M ago
Infant Bacterial Therapeutics AB Gains FDA Breakthrough Status for IBP-9414
PremiumCompany Announcements
Infant Bacterial Therapeutics AB Gains FDA Breakthrough Status for IBP-9414
11M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >